Healthcare remains a highly attractive sector, supported by a tidal wave of innovation in both therapeutics and the provision of healthcare services BB Healthcare team is now building up on 2017 outperformance (+4.9%, despite currency headwinds) and asset growth Expect 2018 stocks' performance to be driven more by fundamentals (and M&A), less by political issues (tax reforms, Obamacare repeal) BB Healthcare portfolio best positioned to capture the strongest emerging themes in healthcare, acro...
​Building on the expertise acquired with BB Biotech, the largest European biotech investment trust with over $3 billion under management and 25-year track record, in December 2016 Bellevue Asset Management launched the BB Healthcare trust (BBH), a highly differentiated product in the market of actively managed funds.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.